References
- Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases. Drugs 1979; 18: 417–438
- Caldwell J., Hutt A. J. Methodology for the isolation and characterization of conjugates of xenobiotic carboxylic acids. Progress in Drug Metabolism, J. W. Bridges, L. F. Chasseaud. Taylor & Francis, London 1986; Vol. 9: 11–51
- Camus J. P., Amor B., Asch L., Bontoux D., Bregeon C., Caporal R., Fournie A., Freneaux B., Laffez B., Loyau G., Pawlotsky Y., Phelip X. Long term tolerance of a new NSAID ximoprofen. XVIIth ILAR Congress of Rheumatology 1989, Abstr. P95
- Caproral R., Dougados M., Doury P., Thiesce A., Pattin S., Laffez B., Amor B. A double blind cross-over placebo controlled trial of ximoprofen in ankylosing spondylitis. XVIIth ILAR Congress of Rheumatology 1989, Abstr. P97
- Clay K. L., Watkins W. D., Murphy R. C. Metabolism of pyrazole, structure elucidation of urinary metabolites. Drug Metabolism and Disposition 1977; 5: 149–156
- DeLong A., Smyth R. D., Polk A., Nayak R. K., Martin G., Douglas G. H., Reavey-Cantwell N. H. Comparative metabolism of fenclorac in rat, dog, monkey and man. Drug Metabolism and Disposition 1977; 5: 122–131
- Duggan D. E., Baldwin J. J., Arison B. H., Rhodfs R. E. N-Glucoside formation as a detoxification mechanism in mammals. Journal of Pharmacology and Experimental Therapeutics 1974; 190: 563–569
- Fevery J., Van Der Vijver M., Michiels R., Heirwegh K. P. M. Comparison in different species of bilary bilirubin-IXα conjugates with activities of hepatic and renal bilirubin-IXα-uridine diphosphate glycosyltransferases,. Biochemical Journal 1977; 164: 737–746
- Hucker H. B., Zacchei A. G., Cox S. V., Brodie D. A., Cantwell N. H. R. Studies on the absorption, distribution and excretion of indomethacin in various species. Journal of Pharmacology and Experimental Therapeutics 1966; 153: 737–746
- Hucker H. B., Kwan K. C., Duggan D. E. Pharmacokinetics and metabolism of nonsteroidal anti-inflammatory agents. Progress in Drug Metabolism, J. W. Bridges, L. F. Chasseaud. Wiley, Chichester 1980; Vol. 5: 165–253
- Hutt A. J., Caldwell J. The metabolic chiral inversion of 2-arylpropionic acids—a novel route with pharmacological consequences. Journal of Pharmaceutics and Pharmacology 1983; 35: 693–704
- Janssen F. W., Kirkman S. K., Fenselau C., Stogniew M., Hofmann B. R., Young E. M., Reulius H. W. Metabolic formation of N-and O-glucuronides of 3-(p-chlorophenyl) thiazolo[3,2-a]benzimidazole-2-acetic acid. Drug Metabolism and Disposition 1982; 10: 599–604
- Klaassen C. D., Eaton D. L., Cagen S. Z. Hepatobiliary disposition of xenobiotics. Progress in Drug Metabolism, J. W. Bridges, L. F. Chasseaud. Wiley, Chichester 1981; Vol. 6: 1–75
- Maillard J., Langlois M., Delaunay P., van Vo T., Meingan J. P., Rapin M., Morin R., Manuel C., Mazmanian C. Antiinflammatory phenylacetic acid derivatives. III. 4-cyclohexyl-phenylacetic acid oxygenated derivative. European Journal of Medicine, Chem Chimica Therapeutica 1977; 12: 161–171
- Midgley I., Hawkins D. R., Chasseaud L. F. The metabolic fate of the antidepressive agent amitriptylin-oxide in man,. Arzneimittel-Forschung 1978; 28: 1911–1916
- Riess W., Stierlin H., Geiger U. P., Gerardin A., Schmid K., Wagner J., Theobald W. Data on the pharmacokinetics and metabolism of diclofenac (Voltaren) in animals and man. Chronic Forms of Polyarthritis, F. J. Wagenhauser. Huber Verlag, Bern 1977; 302–319
- Risdall P. C, Adams S. S., Crampton E. L., Marchant B. The disposition and metabolism of Flurbiprofen in several species including man. Xenobiotica 1978; 8: 691–704
- Rubio F., Seawall S., Pocelinko R., De Barbieri B., Benz W., Berger L., Morgan L., Pao J., Williams T. H., Koechlin B. Metabolism of Carprofen, a non-steroidal antiinflammatory agent in rats, dogs and humans. Journal of Pharmaceutical Sciences 1980; 69: 1245–1254
- Schwartz M. A., Kolis S. J., Williams T. H., Gabriel T. F., Toome V. Biotransformation of 2-hydroxynicotinic acid: N-riboside formation in vivo. Drug Metabolism and Disposition 1973; 1: 557–564